Thursday, May 29th, 2025
Stock Profile: AMRN

Amarin Corporation plc (AMRN)

Market: NASD | Currency: USD

Address: Iconic Offices, The Greenway

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly Show more




📈 Amarin Corporation plc Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2025 - $0.050000 - 2025-04-11 - Stock split
Total Amount for 2025: $0.050000


📅 Earnings & EPS History for Amarin Corporation plc


DateReported EPS
2025-03-12-0.03
2024-10-30-0.06
2024-07-31-
2024-05-01-0.02
2024-02-29-0.01
2023-11-01-0.05
2023-08-02-0.04
2023-05-03-0.04
2023-03-01-
2022-10-27-0.01
2022-08-03-0.11
2022-05-04-0.08
2022-03-010.04
2021-11-03-0.03
2021-08-050.02
2021-04-29-
2021-02-250.01
2020-11-05-0.02
2020-08-040.01
2020-04-30-0.06
2020-02-250.02
2019-11-05-0.01
2019-07-31-0.01
2019-05-01-0.07
2019-02-27-0.11




📰 Related News & Research


No related articles found for "amarin corporation".